Teva Pharmaceuticals USA Inc
Lobbying group · Jul 2025 – Sep 2026
Teva Pharmaceuticals USA Inc spent $2.3M lobbying the federal government (Jul 2025 – Sep 2026), mostly on health care, tariffs, copyright & patents. It used 8 lobbyists, including people who worked for 1 members of Congress.
- Spent on lobbying
- $2.3M
- Lobbyists
- 8
- Bills lobbied
- 4
- Issues
- 7
Spending by quarter
- 2025 Q3$460K
- 2025 Q4$360K
- 2026 Q1$1.1M
- 2026 Q2$380K
Issues lobbied
- Health care
- Tariffs
- Copyright & patents
- Medicare & Medicaid
- Trade
- Pharmacy
- Manufacturing
Bills lobbied on
- S.J.Res. 37: A joint resolution terminating the national emergency declared to impose duties on…4 reports
- H.R. 18434 reports
- S. 959: Tariff Transparency Act of 20253 reports
- H.R. 68883 reports
Lobbying firms hired
- Teva Pharmaceuticals USA, Inc.$2.3M
- Mr. David Friedman$450K
- Faegre Drinker Biddle & Reath LLP$240K
- Capitol Hill Consulting Group$240K
- Talley Strategies LLC$100K
Lobbyists who worked in Congress
- Megan Herber
Legislative Director/Senior Legislative Assistant/Legislative Assistant, Rep. Doris Matsui (D-CA) 2014-2018Doris O. Matsui (D-CA)
Agencies contacted
- House Of Representatives · 32
- Senate · 32
- Health & Human Services, Dept of (Hhs) · 16
- Commerce, Dept of (Doc) · 12
- Executive Office of the President (Eop) · 8
- Food & Drug Administration (Fda) · 8
Related
Filings
- 2026 Q2 report$60K
- 2026 Q2 report$380K
- 2026 Q2 report$60K
- 2026 Q1 report$60K
- 2026 Q1 report$1.1M
From Lobbying Disclosure Act reports filed with the Senate and House.
Cite or embed this page
Capitol Receipts, “Teva Pharmaceuticals USA Inc: Lobbying Spending, Issues & Bills,” https://www.capitolreceipts.com/lobbying/ctevapharmaceuticalsusa/teva-pharmaceuticals-usa-inc (accessed 2026-10-16).